Tuesday, January 14, 2025 12:40:24 PM
Just out…
Attention $KRTL shareholders:
We’re proud to announce that our wholly owned subsidiary, KRTL Biotech Inc., has achieved two major regulatory milestones: FDA Facility Establishment Identifier (FEI) number and National Drug Code (NDC) registration. 🎉 A big step forward in pharmaceutical manufacturing!
Attention $KRTL shareholders:
— KRTLBIOTECH OTC:KRTL (@KRTLBiotech) January 14, 2025
We’re proud to announce that our wholly owned subsidiary, KRTL Biotech Inc., has achieved two major regulatory milestones: FDA Facility Establishment Identifier (FEI) number and National Drug Code (NDC) registration. 🎉 A big step forward in…
Attention $KRTL shareholders:
We’re proud to announce that our wholly owned subsidiary, KRTL Biotech Inc., has achieved two major regulatory milestones: FDA Facility Establishment Identifier (FEI) number and National Drug Code (NDC) registration. 🎉 A big step forward in pharmaceutical manufacturing!
PROTECT YOUR ASS-ets!!
Recent KRTL News
- KRTL HOLDING GROUP INC. REPORTS THIRD QUARTER 2025 RESULTS (UNAUDITED) AND FILES PCAOB-AUDITED 2024 AND 2023 FINANCIAL STATEMENTS • GlobeNewswire Inc. • 11/17/2025 02:00:00 PM
- KRTL Biotech Spotlights Anti-Infectives and Antibiotics Portfolio to Support Public Health and Global Treatment Access • GlobeNewswire Inc. • 10/28/2025 01:00:00 PM
- KRTL Biotech Highlights ELIXIR as Flagship Hydration Product in Bolivia • GlobeNewswire Inc. • 10/02/2025 01:00:00 PM
- KRTL Holding Group, Inc. Announces Merger with Industria Químico Farmacéutica Sigma Corp. S.R.L. • GlobeNewswire Inc. • 09/09/2025 01:00:00 PM
